Altre lingue Neumora Therapeutics, Inc.

Azioni

NMRA

US6409791000

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
9,19 ^USD	-5,94%		-0,65%	-46,10%

07/05	Le azioni di Neumora Therapeutics scendono quando la perdita del primo trimestre si restringe	MT
07/05	Neumora Therapeutics, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Neumora Therapeutics Shares Fall as Q1 Loss Narrows	07/05
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	07/05
Neumora Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Neumora Therapeutics to Participate in Upcoming Conferences in May	06/05
Sector Update: Health Care Stocks Advance Premarket Monday	15/04
Sector Update: Health Care	15/04
Investors Shrug Off Geopolitical Concerns, Driving Premarket Gains for US Equity Futures	15/04
Upcoming Earnings Buoy Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday	15/04
Top Premarket Decliners	15/04
Neumora Therapeutics' Phase 1 Trial of Potential Brain Disease Drug on Hold After Convulsions in Rabbits	15/04
Neumora Shares Slide Premarket as FDA Puts Early Study of Schizophrenia Drug on Hold	15/04
Neumora's early-stage schizophrenia drug study put on hold	15/04
U.S. FDA places clinical hold on Neumora's schizophrenia drug study	15/04
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study	15/04
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study	15/04
Neumora Therapeutics, Inc.(NasdaqGS:NMRA) added to S&P Global BMI Index	18/03
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days	13/03
Certain Common Stock of Neumora Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-MAR-2024.	12/03
Certain Stock Options of Neumora Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-MAR-2024.	12/03
Neumora Therapeutics Q4 Loss Narrows	07/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Neumora Therapeutics, Inc.

Azioni

NMRA

US6409791000

Altre lingue

Filtri